MGB said it will continue to cover Wegovy, a rival GLP-1 from Novo Nordisk, and three other obesity drugs
Strong GH release, strong appetite stimulation, moderate cortisol and prolactin elevation
Ozempic has also been approved by the FDA to lower the risk of heart attack, stroke, or death in adults with type 2 diabetes mellitus and known heart disease
When an employer purchases a health insurance plan for their employees, they can opt in or opt out of the coverage of medications for the treatment of obesity, explains Sarah Stombaugh, MD, an obesity medicine physician
The real question: how do you keep the weight off once the drug is gone
The table below is not a dosing guide, treatment recommendation or human-use instruction